TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment

Figure 1

Analysis of the TREM2 expression in TCGA datasets and the Human Protein Atlas. (a) Validation of higher TREM2 mRNA expression in SKCM than that in normal tissue in TCGA datasets. (b, c) The level of TREM2 protein in melanoma tissue was higher than that in normal skin tissue in the Human Protein Atlas (antibody HPA010917).

(a)

(b)

(c)